Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rethinking bronchiectasis as an inflammatory disease
Merete Long, Sanjay H. Chotirmall, Michal Shteinberg, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 11, pp. 901-914
Closed Access | Times Cited: 12

Showing 12 citing articles:

TheEuropean Respiratory Journal: our drive to thrive in ’25!
James D. Chalmers, Neil J. Bullen, Don D. Sin
European Respiratory Journal (2025) Vol. 65, Iss. 1, pp. 2500047-2500047
Closed Access
Relation between vitamin D deficiency and Pseudomonas aeruginosa colonization in patients with bronchiectasis
Yaoshen Wen, Ruoxuan Dai, Heng Yang, et al.
BMC Pulmonary Medicine (2025) Vol. 25, Iss. 1
Open Access
Challenges in treating patients with comorbid asthma and bronchiectasis
Mario Cazzola, Luigino Calzetta, Maria Gabriella Matera, et al.
Respiratory Medicine (2025), pp. 107957-107957
Closed Access
Bronchiektasie: Entzündlicher Charakter im Vordergrund?

Pneumologie (2025) Vol. 79, Iss. 02, pp. 111-112
Closed Access
Unbreak my heart: macrolide cardiovascular benefits and safety in bronchiectasis
Benjamin Jaa Ming New, James D. Chalmers
European Respiratory Journal (2025) Vol. 65, Iss. 3, pp. 2500045-2500045
Closed Access
Research Progress of the Bronchiectasis in Children with Inborn Errors of Immunity
敏 田
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 1330-1337
Closed Access
Eosinophilic Bronchiectasis: Prevalence, Severity, and Associated Features—A Cohort Study
Raffaele Campisi, Santi Nolasco, M. Mancuso, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4932-4932
Open Access | Times Cited: 3
The bronchiectasis microbiome: current understanding and treatment implications
Jayanth Kumar Narayana, Micheál Mac Aogáin, Philip M. Hansbro, et al.
Current Opinion in Pulmonary Medicine (2024)
Closed Access | Times Cited: 1
Immunological characterization of IgG subclass deficiency reveals decreased Tregs and increased circulating costimulatory and regulatory immune checkpoints
Per Wågström, Maria Hjorth, Daniel Appelgren, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
The impact of Tanreqing injection on mucus hypersecretion and cough in bronchiectasis: A meta-analysis of randomized controlled trials
Jinzhi Zhang, Zi Yang, Shasha Yuan, et al.
Medicine (2024) Vol. 103, Iss. 45, pp. e40465-e40465
Open Access
New thinking and a new direction in bronchiectasis
Ian Pavord
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 11, pp. 844-845
Closed Access
Disease Severity and Activity in Bronchiectasis: A Paradigm Shift in Bronchiectasis Management
Yunjoo Im, James D. Chalmers, Hayoung Choi
Tuberculosis & respiratory diseases (2024) Vol. 88, Iss. 1, pp. 109-119
Open Access
Page 1

Scroll to top